Stay updated on Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.

Latest updates to the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision tag (v3.6.6) was added to the record history, replacing the previous v3.6.5. This indicates an updated version of the page history without altering substantive study information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry labeled v3.6.5 appears in the history, and the previous v3.6.4 entry is removed, updating the record's version history.SummaryDifference0.1%

- Check47 days agoChange DetectedThe study history page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a new build of the page UI.SummaryDifference0.1%

- Check62 days agoChange DetectedThe record history shows termination for futility and posting of results, with Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow added under the Study Status/Document sections. A prior change to Completed and Results Submitted was removed from the history on 2025-10-22.SummaryDifference0.8%

- Check69 days agoChange DetectedA new history entry 'Revision: v3.6.3' was added, replacing the previous 'Revision: v3.6.2'. This reflects a platform/version update to the study record history display and does not modify the study content.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a new release of the study history page. The update does not change study content or navigation.SummaryDifference0.1%

Stay in the know with updates to Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.